Announced
Completed
Synopsis
Vivalto Partners, a French private equity firm dedicated to healthcare, completed the acquisition of Linnea, a Swiss-based active pharma ingredients producer. Financial terms were not disclosed. "This transaction marks a significant milestone for Vivalto Partners and represents a primary buyout, with a substantial investment from Linnea’s management team to support the company’s continued growth and innovation in the fast-expanding field of plant-based therapeutics and botanical ingredients," Vivalto Partners statement.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealSeller Team (3)
Bidder Team (5)
Vendor Team (4)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite